Injongo yocwaningo

Inhloso yalolu cwaningo ukuhlola ukusebenza kahle nokuphepha kwe-opevesostat plus hormone replacement therapy (HRT) uma kuqhathaniswa nenye i-abiraterone acetate noma i- enzalutamide kubabambiqhaza abanomdlavuza wendlala yesinye we-Metastatic Castration-resistant (mCRPC) abake belashwa kusetshenziswa i-ejenti ye-hormone yesizukulwane esilandelayo (NHA). Imibono yocwaningo eyinhloko iwukuthi i-opevesostat iphakeme kunenye i-abiraterone acetate noma i-enzalutamide ngokuphathelene ne-radiographic progression free survival (rPFS) ngokwe-Prostate Cancer Working Group (PCWG) Imibandela Yokuhlola Ukusabela Okuguquliwe Kuma-Solid Tumors (RECIST 1.1) njengoba ihlolwe yi-Blinded Independent Central Review (i-BICR) (i-BICRval Independent) Isibuyekezo se-OS Ephakathi (i-BICRval Independent) kanye ne-OS Ephakathi isizinda esibophezelayo se-ligand (AR LBD) ukuguqulwa kwabahlanganyeli aba-negative naba-positive.

Isihlonzi se- Clinicaltrials.gov

I-NCT06136650

I-EU CT

2023-504957-11-00

Lapho uxoxa nodokotela wakho noma ilungu leqembu locwaningo lwezokwelapha, sicela ube nenombolo yereferensi yocwaningo noma inombolo ye-EudraCT.

Izinsiza

Ukufaneleka

Uchwepheshe wezempilo uyena kuphela onganquma ukuthi uyafaneleka yini ukubamba iqhaza ocwaningweni lwezokwelapha. Nokho, lolu lwazi lungaba usizo ekuqaleni ingxoxo nodokotela wakho.

Izimo Icon

Izimo

We-Prostate We-Metastatic Castration-resistant

Ububanzi Bobudala Icon

Ububanzi Bobudala

18+

Ubulili Icon

Ubulili

Owesilisa

Trial phase Icon Isigaba socwaningo esiqhubekayo

Isigaba ISIGABA3 Socwaningo

Ezingcwaningweni Zesigaba 3, abacwaningi bazama ukuthola ukuthi umuthi ungasebenza yini enanini elikhulu labantu, ngokuvamile ababambiqhaza abayi-1,000 ukuya ku-5,000 abanesimo sempilo esizokwelashwa umuthi. Ezingcwaningweni zomgomo, ababambiqhaza bangaba abanempilo noma abanezifo noma izimo ezithile. Ucwaningo lwesigaba 3 lungenziwa ehhovisi likadokotela, emtholampilo, noma esibhedlela.

Trial start Icon Izinsuku zokuqala nokuqedwa kocwaningo
  • Usuku lokuqala kocwaningo Disemba 18, 2023
  • Usuku oluyinhloko lokuqeda olulinganiselwe Disemba 2, 2030
  • Usuku lokuqeda ucwaningo olulinganiselwe Disemba 2, 2030

Izindawo zocwaningo

Asilitholi igama elifana nalelo oliseshayo. Sicela uzame futhi.

Yikuphi ongakwenza ngokulandelayo?

Uma ucabanga ukuthi lolucwaningo lwezokwelapha lungakulungela futhi unesithakazela sokubamba iqhaza, ukuthatha isinyathelo esilandelayo ukuze ubone ukuthi uyafaneleka yini.

Xoxa nodokotela wakho noma iqembu lokunakekela

Phrintha leli khasi elinemininingwane yocwaningo noma ulithumele nge-imeyili kudokotela wakho ukuxoxa ngocwaningo lwezokwelapha ekuvakasheni okulandelayo.

Thola usizo ngokuxoxa nodokotela wakho noma iqembu lokunakekela

Isihlonzi se- Clinicaltrials.gov

I-NCT06136650

I-EU CT

2023-504957-11-00

Lapho uxoxa nodokotela wakho noma ilungu leqembu locwaningo lwezokwelapha, sicela ube nenombolo yereferensi yocwaningo noma inombolo ye-EudraCT.

Ukubamba iqhaza ocwaningweni lwezokwelapha kuyisinqumo esibalulekile

Uma ucabangela ukujoyina ucwaningo lwezokwelapha, qala ngokufunda okuningi ngokunokwenzeka ngalo:

  • Umuthi wophenyo ocwaningwayo
  • Yiziphi izingozi noma izinzuzo ezingaba khona zababambiqhaza

Xoxa nodokotela wakho ngocwaningo lwezokwelapha ungakenzi isinqumo sokujoyina.

Funda ikhasi elithi “Ongakucabangela” ukuthola imibuzo eyengeziwe ongayibuza nongacabanga ngayo